Filter Results
:
(2,463)
Show Results For
-
All HBS Web
(2,463)
- People (4)
- News (536)
- Research (1,443)
- Events (10)
- Multimedia (31)
- Faculty Publications (943)
Show Results For
-
All HBS Web
(2,463)
- People (4)
- News (536)
- Research (1,443)
- Events (10)
- Multimedia (31)
- Faculty Publications (943)
- March 2011 (Revised June 2012)
- Case
Office of Technology Transfer - Shanghai Institutes for Biological Sciences
By: Willy Shih, Sen Chai, Kamen Bliznashki and Courtney Hyland
Gordon Zong is trying to teach Chinese universities and research institutes how to do effective technology transfer and IP licensing, but he is trying to do it in an environment with weak property rights and an underdeveloped support infrastructure. As the managing...
View Details
Keywords:
Multinational Firms and Management;
Patents;
Knowledge Management;
Law Enforcement;
Business and Government Relations;
Research and Development;
Biotechnology Industry;
Pharmaceutical Industry;
China
Shih, Willy, Sen Chai, Kamen Bliznashki, and Courtney Hyland. "Office of Technology Transfer - Shanghai Institutes for Biological Sciences." Harvard Business School Case 611-057, March 2011. (Revised June 2012.)
- 2013
- Book
Happy Money: The Science of Happier Spending
By: Elizabeth Dunn and Michael Norton
If you think money can't buy happiness, you're not spending it right. Two rising stars in behavioral science explain how money can buy happiness—if you follow five core principles of smarter spending. Happy Money offers a tour of new research on the science of...
View Details
Dunn, Elizabeth, and Michael Norton. Happy Money: The Science of Happier Spending. New York: Simon & Schuster, 2013.
- 11 AM – 2:30 PM EDT, 06 May 2021
- Virtual Programming
SEAS Nexus: Innovation + Impact
An exosuit to relieve disability. A battery that runs on renewable energy. A 3D printer that prints living tissue. These are but a few examples of high-impact, translational research commercialized by SEAS faculty and students. Each day they leverage the breadth and...
View Details
- March 2005 (Revised May 2011)
- Course Overview Note
Conceptual Overview of Real Property
By: Arthur I Segel and Ann Winslow
Real estate represents the largest asset class in the world. Businesses in the United States have over $8.6 trillion of real estate assets on their balance sheets. Excluding housing--worth $16 trillion in the United States--and corporate-owned real estate, there is...
View Details
Keywords:
Property
- April 1993 (Revised May 1994)
- Case
Genzyme Corporation: Strategic Challenges with Ceredase
Genzyme Corp., one of the largest biotechnology companies, has succeeded in developing, manufacturing, and commercializing its first therapeutic, a treatment for a rare genetic disease. Analysis of the case requires students to identify and understand how Genzyme has...
View Details
Keywords:
Risk Management;
Risk and Uncertainty;
Corporate Strategy;
Technology;
Health;
Product Development;
Biotechnology Industry;
Pharmaceutical Industry;
United States
Teisberg, Elizabeth O., and Sharon L. Rossi. "Genzyme Corporation: Strategic Challenges with Ceredase." Harvard Business School Case 793-120, April 1993. (Revised May 1994.)
- June 2019
- Article
Financial Development and Technology Diffusion
By: Diego Comin and Ramana Nanda
We examine the extent to which financial market development impacts the diffusion of 16 major technologies, looking across 17 countries, from 1870 to 2000. We find that greater depth in financial markets leads to faster technology diffusion for more capital-intensive...
View Details
Comin, Diego, and Ramana Nanda. "Financial Development and Technology Diffusion." IMF Economic Review 67, no. 2 (June 2019): 395–419.
- June 2013 (Revised January 2016)
- Case
Château Margaux: Launching the Third Wine
By: Elie Ofek and Eric E. Vogt
Château Margaux, one of only five prestigious estates in the Bordeaux Medoc wine region to have been classified as a "first-growth", is facing a host of strategic decisions in early 2013. Up until this point the estate had been selling two red wines, a first wine whose...
View Details
Keywords:
New Product Launch;
Marketing Plan;
Brand Management;
Go To Market Strategy;
Channels Of Distribution;
Wine Industry;
Marketing Strategy;
Distribution Channels;
Product Launch;
Brands and Branding;
Agriculture and Agribusiness Industry;
Food and Beverage Industry;
France
Ofek, Elie, and Eric E. Vogt. "Château Margaux: Launching the Third Wine." Harvard Business School Case 513-107, June 2013. (Revised January 2016.)
- 2024
- Working Paper
Magnetic Resonance Imaging—High Quality and Radiation Free: Case Histories of Transformational Advances
By: Srikant M. Datar, Amar Bhidé and Katherine Stebbins
This case history describes how Magnetic Resource Imaging (MRI) came to complement – and partially replace -- computed tomography (CT) imaging of soft tissue. Specifically, we chronicle 1) the development of foundational techniques and prototypes (through the 1970s);...
View Details
Keywords:
Health Care and Treatment;
Technological Innovation;
Innovation Strategy;
Technology Adoption;
Collaborative Innovation and Invention;
Innovation and Invention;
Governing Rules, Regulations, and Reforms
Datar, Srikant M., Amar Bhidé, and Katherine Stebbins. "Magnetic Resonance Imaging—High Quality and Radiation Free: Case Histories of Transformational Advances." Harvard Business School Working Paper, No. 20-001, July 2019. (Revised May 2024.)
- February 2013 (Revised February 2013)
- Case
King Abdullah Economic City in 2009: Population Drivers and Cash Flow
By: John D. Macomber
CEO of high profile new economic city in Saudi Arabia must decide how to allocate limited investment funds across projects under duress. Issues include understanding core economic drivers, planning infrastructure investment and return, attracting multinationals, energy...
View Details
Julie Battilana
Julie Battilana is the Joseph C. Wilson Professor of Business Administration in the Organizational Behavior unit at Harvard Business School and the Alan L. Gleitsman Professor of Social Innovation at Harvard Kennedy School, where she is also the founder and faculty... View Details
- December 2023
- Case
Davivienda Bank's Upskilling and Reskilling Strategy in Colombia
By: Jorge Tamayo, Raffaella Sadun and Jenyfeer Martinez Buitrago
Set in 2022, this case describes the digital transformation strategy of Davivienda— a leading player in Colombia’s commercial banking and one of the companies belonging to Grupo Bolívar, a major Colombian financial conglomerate—and the bank’s upskilling and reskilling...
View Details
Keywords:
Change Management;
Transformation;
Decision Choices and Conditions;
Digital Strategy;
Digital Transformation;
Internet and the Web;
Mobile and Wireless Technology;
Innovation and Management;
Innovation Strategy;
Growth and Development Strategy;
Business Strategy;
Corporate Strategy;
Organizational Culture;
Talent and Talent Management;
Training;
Banking Industry;
Latin America;
Central America;
South America;
Colombia
Tamayo, Jorge, Raffaella Sadun, and Jenyfeer Martinez Buitrago. "Davivienda Bank's Upskilling and Reskilling Strategy in Colombia." Harvard Business School Case 724-425, December 2023.
- 01 Nov 2012
- HBS Seminar
Joel Waldfogel, University of Minnesota
- January 1996
- Case
Palm Computing, Inc. (A)
By: Myra M. Hart
Discusses patents, licenses, and deal making in a start-up venture. The entrepreneur, Jeff Hawkins, holds a patent on Palm Print, a pattern recognition algorithm. After licensing Palm Print to his employer, he led three years of development of commercial products for...
View Details
Keywords:
Intellectual Property;
Patents;
Agreements and Arrangements;
Negotiation Deal;
Business Startups;
Management Teams
Hart, Myra M. "Palm Computing, Inc. (A)." Harvard Business School Case 396-245, January 1996.
- August 2009 (Revised March 2011)
- Case
Shenzhen Development Bank
By: Li Jin, Yuhai Xuan and Xiaobing Bai
Weijian Shan, Managing Partner of Newbridge Capital, faces a tough call in regard to his firm's investment in Shenzhen Development Bank, China's fifteenth-largest commercial bank listed on the Shenzhen Stock Exchange. Due to the aggressive lobby of the existing...
View Details
Keywords:
Mergers and Acquisitions;
Private Equity;
Commercial Banking;
Investment;
Emerging Markets;
Business and Government Relations;
Banking Industry;
China
Jin, Li, Yuhai Xuan, and Xiaobing Bai. "Shenzhen Development Bank." Harvard Business School Case 210-020, August 2009. (Revised March 2011.)
- April 1998
- Case
Cephalon, Inc.
By: Peter Tufano
In early 1997, Cephalon, awaited an FDA panel's decision on whether its drug, Myotrophin, would be approved. If the drug was approved, the firm might need substantial additional funds to commercialize as well as to buy back rights to it (which had been sold earlier to...
View Details
Keywords:
Risk Management;
Financing and Loans;
Health Care and Treatment;
Pharmaceutical Industry;
United States
Tufano, Peter, Geoffrey Verter, and Markus Mullarkey. "Cephalon, Inc." Harvard Business School Case 298-116, April 1998.
- August 2007 (Revised October 2022)
- Case
Ken Durham and Unilever as a 'Multi-Local Multinational'
By: Geoffrey Jones and Stephanie Decker
Explores the opportunities and threats to Unilever's global business in 1978 based on the commercial and political challenges faced by three of its subsidiaries, Lever Brothers in the United States, Hindustan Lever in India, and United Africa Company in West Africa....
View Details
Keywords:
Business Divisions;
Local Range;
Global Strategy;
Multinational Firms and Management;
Management Style;
Competitive Strategy;
Africa;
India;
United States
Jones, Geoffrey, and Stephanie Decker. "Ken Durham and Unilever as a 'Multi-Local Multinational'." Harvard Business School Case 808-025, August 2007. (Revised October 2022.)
- February 2009 (Revised December 2010)
- Case
Upgrading the Economy: Industrial Policy and Taiwan's Semiconductor Industry
By: Willy C. Shih and Jyun-Cheng Wang
The government-led creation and incubation of the semiconductor industry in Taiwan is a striking success for advocates of strong industrial policy. It has led to the island nation's domination of the global "foundry" business in which firms like Taiwan Semiconductor...
View Details
Keywords:
Economic Growth;
Industry Structures;
State Ownership;
Business and Government Relations;
Competition;
Semiconductor Industry;
Taiwan
Shih, Willy C., and Jyun-Cheng Wang. "Upgrading the Economy: Industrial Policy and Taiwan's Semiconductor Industry." Harvard Business School Case 609-089, February 2009. (Revised December 2010.)
- July 1997 (Revised April 1998)
- Case
Chase Manhattan Corporation: The Making of America's Largest Bank
By: Stuart C. Gilson and Cedric Escalle
Chase Bank and Chemical Bank intend to merge, producing the largest commercial bank in the United States, the fourth largest in the world. Projected financial benefits under the merger reflect significant planned reduction in operating costs, including 17,000 employee...
View Details
Keywords:
Commercial Banking;
Profit;
Corporate Strategy;
Value Creation;
Restructuring;
Negotiation;
Mergers and Acquisitions;
Risk and Uncertainty;
Resignation and Termination;
Revenue;
Banking Industry;
United States
Gilson, Stuart C., and Cedric Escalle. "Chase Manhattan Corporation: The Making of America's Largest Bank." Harvard Business School Case 298-016, July 1997. (Revised April 1998.)
- December 2008 (Revised October 2013)
- Case
Amylin Pharmaceuticals: Diabetes and Beyond (A)
By: Richard G. Hamermesh and Rachel Gordon
Ginger Graham, CEO of Amylin Pharmaceuticals, joined the company with the expectation of taking the company's signature drug, Symlin, to market. However, unforeseen regulatory challenges have put the approval process in jeopardy. At the same time, the company has a...
View Details
Keywords:
Regulations;
Drug Regulations;
Symlin;
Negotiation;
Governing Rules, Regulations, and Reforms;
Resource Allocation;
Negotiation Deal;
Product Development;
Research and Development;
Commercialization;
Pharmaceutical Industry;
United States
Hamermesh, Richard G., and Rachel Gordon. "Amylin Pharmaceuticals: Diabetes and Beyond (A)." Harvard Business School Case 809-011, December 2008. (Revised October 2013.)
- 2022
- Working Paper
How Do Copayment Coupons Affect Branded Drug Prices and Quantities Purchased?
By: Leemore S. Dafny, Kate Ho and Edward Kong
Drug copayment coupons to reduce patient cost-sharing have become nearly ubiquitous for high-priced brand-name prescription drugs. Medicare bans such coupons on the grounds that they are kickbacks that induce utilization, but they are commonly used by...
View Details
Keywords:
Prescription Drugs;
Coupons;
Impact;
Health Care and Treatment;
Markets;
Price;
Spending;
Pharmaceutical Industry;
United States
Dafny, Leemore S., Kate Ho, and Edward Kong. "How Do Copayment Coupons Affect Branded Drug Prices and Quantities Purchased?" NBER Working Paper Series, No. 29735, February 2022.